FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

14670911000001107: Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
50865801000001115 Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
50865901000001114 Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Is a Octreotide 500micrograms/mL injection solution 1mL ampule false Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has active ingredient Octreotide false Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has active ingredient Octreotide acetate true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Is a Sandostatin true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has specific active ingredient Octreotide acetate true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has dispensed dose form Conventional release solution for injection true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Has basis of strength substance Octreotide true Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Is a Octreotide 500micrograms/1ml solution for injection ampoules false Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Is a Octreotide 500micrograms/1ml solution for injection ampoules true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) 5 ampoule Is pack of False Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier
Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) 5 ampoule Has AMP True Sandostatin 500micrograms/1ml solution for injection ampoules (Sigma Pharmaceuticals Plc) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start